CulosKACuellarS. Novel targets in the treatment of advanced melanoma: new first-line treatment options. Ann Pharamcother. 2013;47:519-526.
2.
O’DaySJMaioMChiarion-SileniV. Efficacy and safety of ipilimumab monotherapy in patients with pre-treated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol. 2010;21:1712-1717.
3.
DiGiacomoAMBiagioliMMaioM. The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications. Semin Oncol. 2010;37:499-507.
4.
JinnurPLimKG. Severe acute orthopnea: ipilimumab-induced bilateral phrenic nerve neuropathy [published online May 9, 2015]. Lung.
5.
ManousakisGKochJSommervilleRB. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve. 2013;48:440-444.
